UCOMB-真实生活数据:慢性病患者的治疗策略
Petra Staubach1, Benedikt Bilo1, Joachim W Fluhr2,3
1Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
The Journal of dermatological treatment
|March 20, 2024
概括
关于慢性疹与并发症治疗的现实数据有限. 这项研究表明,结合治疗慢性疹是可行的和安全的,即使与其他健康状况.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 有限的现实世界安全数据存在慢性疹 (CU) 治疗,当患者有药物和并发症.
- 了解复杂患者群体的治疗疗效和安全性对于有效的CU管理至关重要.
研究的目的:
- 在现实环境中评估慢性疹不同治疗策略的安全性和可行性.
- 评估结合各种治疗方式在CU患者的结合性疾病的结果.
主要方法:
- 一个单一中心的UCARE试点研究包括212名患有慢性疹的门诊患者.
- 根据符合指导方针的CU疗法,患者被分为三组.
- 随访时间平均为24.6个月,并详细记录了相关疾病和治疗方法.
主要成果:
- 在212名患者中,有108人 (50.9%) 患有59种已记录的并发病,包括心血管,自身免疫和恶性疾病.
- 治疗范围从奥马利祖马布与抗组胺药物 (A组) 到双重和三重/四重药物组合 (B组和C组).
- 组C增加了第三种药物 (例如蒙特卢卡斯特,环素) 平均4.9个月,证明了可行性.
结论:
- 在患有并发症的患者中,结合慢性疹的治疗方法是可行的.
- 这些联合治疗方法似乎具有良好的安全性.
- 这项研究为管理复杂的慢性疹病例提供了有价值的现实世界的证据.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
Antiasthma Drugs: Leukotriene Modifiers
297
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
297
Hypersensitivities
633
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
633
COPD: Management Using Bronchodilators and Corticosteroids
205
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
205
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442


